 Vident Investment Advisory LLC bought a new position in shares of Immunomedics, Inc. NASDAQ:IMMU in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 14,619 shares of the biopharmaceutical companys stock, valued at approximately 518,000. A number of other institutional investors and hedge funds also recently added ... 